Transcriptic turns into a key podium to various biotech companies

A biotechnology startup that’s seeking to reinvent how biological research is

carried out has raised 13.4 million dollars in a round of funding which is led by

data collective and with participation from new investors WuXi App Tec and

digital science, other existing investors are AME cloud ventures .it is building a

scalable and modern science as a service platform that uses machine learning to

research. Transcriptic has risen around 14million dollar before now and in latest

round represent a continuation of 8.5 million dollars. Fresh funding will be utilized

to Drive Company’s product and expansion plan.

Future plans

The main goal of Trancriptic is to make research cheaper more accessible and

faster so that today’s investment will enable us to deliver further inventive, to

make that a reality. The new funds will allow a company to grow its team to

accommodate further growth by extending the capabilities of the innovative

platform and to increase research productivity. Transcriptic services will enable

scientists to work remotely with a vast swath of data and equipment that will help

out and produce low-cost results in days.

About Transcriptic

Founded out of Menlo Park in 2012 Transcriptic SaaS-based offering serves an

automated remote lab that let all researchers conduct their experiments from the

web browser and receive their results. Since the time the Transcriptic has been

founded we have seen a significant change in how the industry thinks about lab work,

“explained Max Hodak, CEO of Transcriptic. It provides a web-based automated

cellular and molecular biology platform that enables individual institutions and

researchers to control their work and generate data in order to focus on creative


Source: www.crunchbase.com

Transcriptic turns into a key podium to various biotech companies
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top